Candidate malaria vaccine provides lasting protection in NIH-sponsored trials
A malaria vaccine candidate has demonstrated sustained protection against parasite infection and clinical malaria over two years without a booster dose. The vaccine significantly protected women from malaria in pregnancy, offering new strategies to prevent the disease in vulnerable populations.